ConductScience.org, home

Trial · NCT00982020

Results by group20

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Mean Change From Baseline to 52 Weeks in Body Mass Index (BMI) for All ParticipantsOlanzapine/Standard Behavioral Weight Intervention3.64Standard Error .39kilograms per meter squared (kg/m^2)
Mean Change From Baseline to 52 Weeks in Body Mass Index (BMI) for All ParticipantsOlanzapine/Intense Behavioral Weight Intervention2.83Standard Error .40kilograms per meter squared (kg/m^2)
Mean Change From Baseline to Endpoint in Body Mass Index (BMI) for Participants With Duration of Treatment of at Least 6 MonthsOlanzapine/Standard Behavioral Weight Intervention3.36Standard Error 0.41kg/m^2
Mean Change From Baseline to Endpoint in Body Mass Index (BMI) for Participants With Duration of Treatment of at Least 6 MonthsOlanzapine/Intense Behavioral Weight Intervention2.99Standard Error 0.40kg/m^2
Time to Event for 7%, 15%, and 25% Weight Gain for All ParticipantsOlanzapine/Standard Behavioral Weight InterventionTime to First 7% Weight Gain5795% Confidence Interval 44.00 to 84.00days
Time to Event for 7%, 15%, and 25% Weight Gain for All ParticipantsOlanzapine/Intense Behavioral Weight InterventionTime to First 7% Weight Gain5795% Confidence Interval 44.00 to 84.00days
Time to Event for 7%, 15%, and 25% Weight Gain for All ParticipantsOlanzapine/Standard Behavioral Weight InterventionTime to First 15% Weight Gain19795% Confidence Interval 140.00 to 359.00days
Time to Event for 7%, 15%, and 25% Weight Gain for All ParticipantsOlanzapine/Intense Behavioral Weight InterventionTime to First 15% Weight Gain19895% Confidence Interval 141.00 to NAdays
Time to Event for 7%, 15%, and 25% Weight Gain for All ParticipantsOlanzapine/Standard Behavioral Weight InterventionTime to First 25% Weight GainNA95% Confidence Interval NA to NAdays
Time to Event for 7%, 15%, and 25% Weight Gain for All ParticipantsOlanzapine/Intense Behavioral Weight InterventionTime to First 25% Weight GainNA95% Confidence Interval NA to NAdays
Mean Change From Baseline to 52 Weeks in Adolescent Structured Young Mania Rating Scale (YMRS) for Participants With Bipolar I DisorderOlanzapine/Standard Behavioral Weight Intervention-17.66Standard Error 1.75units on a scale
Mean Change From Baseline to 52 Weeks in Adolescent Structured Young Mania Rating Scale (YMRS) for Participants With Bipolar I DisorderOlanzapine/Intense Behavioral Weight Intervention-12.05Standard Error 1.92units on a scale
Mean Clinical Global Impression of Improvement (CGI-I) at 52 Weeks for All ParticipantsOlanzapine/Standard Behavioral Weight Intervention2.04Standard Error 0.15units on a scale
Mean Clinical Global Impression of Improvement (CGI-I) at 52 Weeks for All ParticipantsOlanzapine/Intense Behavioral Weight Intervention2.29Standard Error 0.16units on a scale
Mean Change From Baseline to 52 Weeks in Waist Circumference for All ParticipantsOlanzapine/Standard Behavioral Weight Intervention7.22Standard Error 1.06centimeters (cm)
Mean Change From Baseline to 52 Weeks in Waist Circumference for All ParticipantsOlanzapine/Intense Behavioral Weight Intervention7.31Standard Error 1.11centimeters (cm)
Mean Change From Baseline to 52 Weeks in Clinical Global Impression - Severity (CGI-S) for All ParticipantsOlanzapine/Standard Behavioral Weight Intervention-2.06Standard Error 0.14units on a scale
Mean Change From Baseline to 52 Weeks in Clinical Global Impression - Severity (CGI-S) for All ParticipantsOlanzapine/Intense Behavioral Weight Intervention-1.74Standard Error 0.14units on a scale
Mean Change From Baseline to 52 Weeks in Anchored Version of the Brief Psychiatric Rating Scale for Children (BPRS-C) for Participants With SchizophreniaOlanzapine/Standard Behavioral Weight Intervention-28.00Standard Error 2.83units on a scale
Mean Change From Baseline to 52 Weeks in Anchored Version of the Brief Psychiatric Rating Scale for Children (BPRS-C) for Participants With SchizophreniaOlanzapine/Intense Behavioral Weight Intervention-30.96Standard Error 2.67units on a scale

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00982020/results